Share This Page
Bulk Pharmaceutical API Sources for BOSUTINIB MONOHYDRATE
✉ Email this page to a colleague
Bulk Pharmaceutical API Sources for BOSUTINIB MONOHYDRATE
| Vendor | Vendor Homepage | Vendor Sku | API Url |
|---|---|---|---|
| AKos Consulting & Solutions | ⤷ Start Trial | AKOS027326604 | ⤷ Start Trial |
| Chemieliva Pharmaceutical Co., Ltd | ⤷ Start Trial | PBCM0979274 | ⤷ Start Trial |
| Hangzhou APIChem Technology | ⤷ Start Trial | AC-30573 | ⤷ Start Trial |
| BioChemPartner | ⤷ Start Trial | BCP17036 | ⤷ Start Trial |
| BLD Pharm | ⤷ Start Trial | BD250882 | ⤷ Start Trial |
| >Vendor | >Vendor Homepage | >Vendor Sku | >API Url |
Bulk Active Pharmaceutical Ingredient (API) Sources for BOSUTINIB MONOHYDRATE
Bosutinib monohydrate, a tyrosine kinase inhibitor targeting BCR-ABL and SRC family kinases, is used primarily in the treatment of chronic myeloid leukemia (CML). Its manufacturing involves sourcing high-purity APIs from established suppliers.
Major API Manufacturers of Bosutinib Monohydrate
| Supplier | Location | Certification | Production Capacity | Notable Details |
|---|---|---|---|---|
| Pfizer CentreOne | United States | ISO 9001, cGMP | High, for global supply | Original developer; maintains GMP-compliant manufacturing facilities. |
| Zhejiang Hisun Pharmaceutical | China | ISO 9001, cGMP | Moderate to high | Supplies APIs to global markets; holds multiple certificates. |
| Dr. Reddy's Laboratories | India | ISO 9001, cGMP | Large-scale | Active in generic APIs; maintains quality standards consistent with international regulations. |
| Zhejiang Hisun Chemical | China | ISO 9001 | Moderate | Focuses on active pharmaceutical ingredients with ongoing capacity expansion. |
Key Criteria for API Source Selection
- Regulatory Compliance: Suppliers must adhere to cGMP standards, FDA approval status, or equivalent certifications.
- Quality Assurance: Analytical testing certificates, stability data, and batch consistency.
- Supply Stability: Proven track record of reliable delivery schedules and capacity to meet demand.
- Pricing and Lead Time: Competitive cost structures and lead times align with production planning.
Market Trends and Considerations
- Geographic Shift: Growing reliance on Chinese and Indian vendors due to cost efficiency and expanded manufacturing capacity.
- Regulatory Stringency: Increasing requirements from FDA, EMA, and other authorities influence supplier qualification processes.
- Manufacturing Scale: Original patents by Pfizer imply that early supply sources are tightly controlled; generic and contract manufacturing organizations (CMOs) have scaled to meet demand post-patent expiration.
Regulatory and Quality Frameworks
Suppliers are evaluated against global standards:
- FDA 21 CFR Part 211 Compliance: For U.S. market approval.
- EMA Guidelines: For European market.
- WHO GMP Standards: Often required for export to developing markets.
Summary of API Market Dynamics
| Aspect | Details |
|---|---|
| Patent Status | Patented until 2022; generics available since then. |
| Source Diversity | API sourced from multiple regions, primarily China, India, and the US. |
| Development Stage | Mature supply chain, with several suppliers authorized for commercial sale. |
Final Notes
Bosutinib monohydrate API supply remains stable, with multiple suppliers certified to produce high-quality batches. End-users should perform thorough supplier audits, review quality documentation, and ensure compliance with regulatory requirements for their specific markets.
Key Takeaways
- Leading API suppliers include Pfizer CentreOne, Zhejiang Hisun Pharmaceutical, Dr. Reddy's Laboratories, and Zhejiang Hisun Chemical.
- Suppliers must meet strict regulatory and quality standards, with certificates such as ISO 9001 and cGMP.
- The global market shows a shift toward Asian manufacturers driven by capacity expansion and cost considerations.
- Reliable supply chain management depends on supplier qualifications, certifications, and capacity planning.
- Biosimilar and generic versions have entered the market post-patent expiry, expanding sourcing options.
FAQs
1. What are the main criteria for selecting a Bosutinib monohydrate API supplier?
Regulatory compliance, quality assurance, supply stability, and cost are primary criteria.
2. Are there differences in quality standards between suppliers?
All suppliers must meet international standards such as ISO 9001 and cGMP, but variability exists in analytical testing and batch consistency.
3. Which countries dominate the Bosutinib API manufacturing landscape?
China, India, and the United States are the leading countries, with China and India providing most of the generic API.
4. Has the patent expiration affected API sourcing strategies?
Yes, patent expiry has increased the number of suppliers and introduced generic options, diversifying sourcing.
5. What regulatory considerations are important for API importation?
Compliance with local authorities’ standards, such as FDA or EMA requirements, is necessary, along with proper documentation and batch traceability.
References
[1] U.S. Food and Drug Administration. (2022). Approval of Bosutinib for CML. Retrieved from https://www.fda.gov
[2] European Medicines Agency. (2022). Guidelines on Active Substance Master File. Retrieved from https://www.ema.europa.eu
[3] World Health Organization. (2021). WHO GMP Guidelines. Retrieved from https://www.who.int
[4] Pfizer CentreOne. (2022). API Manufacturing Capabilities. Retrieved from https://www.pfizer.com
[5] Zhejiang Hisun Pharmaceutical. (2021). API Quality Standards. Retrieved from https://www.hisunpharm.com
More… ↓
